unknown
Stage
About
Daya CNS develops novel non-opioid pyridoindole small molecule medications targeting chronic pain, neuropathies, arthritis, substance abuse disorders, and neuropsychiatric conditions.
Explore Daya CNS's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.